Across the world, 2.8mn people live with multiple sclerosis (MS), a neurological disease which damages the nervous system and can devastate the patient’s quality of life.
Digital technology company smartpatient is out to change this. This week, smartpatient announced the arrival of "MyTherapy for MS".
smartpatient’s "MyTherapy" is a popular medication management app, and "MyTherapy for MS" now offers free content specifically for people with multiple sclerosis, helping them to safely medicate. For MS patients, taking the right medication correctly can slow down the disease's progression, which helps patients maintain the best quality of life possible, for longer.
Multiple sclerosis digital healthcare app can help simplify patients lives
Multiple sclerosis symptoms are both invisible and visible, which impact the MS patients’ independence and quality of life. Symptoms include:
- Fatigue, numbness and tingling in limbs
- Muscle weakness and dizziness
- Sexual dysfunction
- Cognitive and emotional impairment
- Walking problems and spasms
- Vision problems
- Bladder and bowel dysfunction
As a daily companion, the "MyTherapy for MS" app can simplify everyday life with MS and support users in cooperating with their doctors and managing the correct medication usage. The app can also help patients document their lives, give reminders for doctor's appointments, assist in preparing for consultations and facilitate the doctor-patient discussion. Patients can also easily reach specially trained pharmaceutical advisors via an expert hotline integrated into the app. With all of the new hurdles caused by MS, the smartpatient app can simplify everyday life.
Top rated healthcare app supports patients with multiple sclerosis
smartpatient are proud of the “MyTherapy” app, which ranks among the best health apps with an average rating of 4.7 stars on Google Play.
“Adherence to therapy is not a given, even in MS,” says Sebastian Gaede, CEO of smartpatient. “With MyTherapy for MS, we can help patients and their doctors understand whether a particular medication works for the patient. This creates acceptance. Together with the support of daily intake reminders, we thus address two major reasons for so-called non-adherence – which in MS can mean faster progression of the disease.
“Many manufacturers by now have learned that user acceptance is the most important success factor for patient apps. With our modular approach, the manufacturers benefit not only from the medication management experience we gained over 9 years and with millions of users, but they also benefit from our specific support layer for MS and from the possibility to tailor the experience for people prescribed their product,” said Gaede.
- Polio in 2022: the virus is back in the post-COVID-19 eraTelehealth & COVID-19
- 5 minutes with John von Benecke, CEO of Locate BioMedical Devices & Pharma
- Medical device manufacturing company Owen Mumford’s goalsMedical Devices & Pharma
- Abbott invests €440m & creates 1000 Irish healthcare jobsMedical Devices & Pharma